Zoltán Petykó
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zoltán Petykó has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Csaba Varga
Szentágothai Research Centre, Department of Physiology, Medical School, University of Pécs, Pécs, Hungary
1 shared publication - Miklós Kecskés
Institute of Physiology, Medical School, University of Pécs, Pécs, Hungary
1 shared publication - Nóra Henn-Mike
Szentágothai Research Center, Department of Physiology, Medical School, University of Pécs, Pécs, 7624, Hungary
1 shared publication - Szilárd Szőcs
Szentágothai Research Center, Department of Physiology, Medical School, University of Pécs, Pécs, 7624, Hungary
1 shared publication - Ágnes Agócs-Laboda
Szentágothai Research Center, Department of Physiology, Medical School, University of Pécs, Pécs, 7624, Hungary
1 shared publication
Latest Publications
- Open Access
- 10 December 2020
- Published by Springer Nature in Communications Biology
- Vol. 3 (1) , 1-13
Somatostatin expressing GABAergic interneurons in the medial entorhinal cortex preferentially inhibit layerIII-V pyramidal cells
GABA released from heterogeneous types of interneurons acts in a complex spatio-temporal manner on postsynaptic targets in the networks. In addition to GABA, a large fraction of GABAergic cells also express neuromodulator peptides. Somatostatin (SOM) containing interneurons, in particular, have been recognized as key players in several brain circuits, however, the action of SOM and its downstream network effects remain largely unknown. Here, we used optogenetics, electrophysiologic, anatomical and behavioral experiments to reveal that the dendrite-targeting, SOM+ GABAergic interneurons demonstrate a unique layer-specific action in the medial entorhinal cortex (MEC) both in terms of GABAergic and SOM-related properties. We show that GABAergic and somatostatinergic neurotransmission originating from SOM+ local interneurons preferentially inhibit layerIII-V pyramidal cells, known to be involved in memory formation. We propose that this dendritic GABA–SOM dual inhibitory network motif within the MEC serves to selectively modulate working-memory formation without affecting the retrieval of already learned spatial navigation tasks.
- 10 December 2020
- Published by Springer Nature in Communications Biology
- Vol. 3 (1) , 1-13
Open AccessSomatostatin expressing GABAergic interneurons in the medial entorhinal cortex preferentially inhibit layerIII-V pyramidal cells
GABA released from heterogeneous types of interneurons acts in a complex spatio-temporal manner on postsynaptic targets in the networks. In addition to GABA, a large fraction of GABAergic cells also express neuromodulator peptides. Somatostatin (SOM) containing interneurons, in particular, have been recognized as key players in several brain circuits, however, the action of SOM and its downstream network effects remain largely unknown. Here, we used optogenetics, electrophysiologic, anatomical and behavioral experiments to reveal that the dendrite-targeting, SOM+ GABAergic interneurons demonstrate a unique layer-specific action in the medial entorhinal cortex (MEC) both in terms of GABAergic and SOM-related properties. We show that GABAergic and somatostatinergic neurotransmission originating from SOM+ local interneurons preferentially inhibit layerIII-V pyramidal cells, known to be involved in memory formation. We propose that this dendritic GABA–SOM dual inhibitory network motif within the MEC serves to selectively modulate working-memory formation without affecting the retrieval of already learned spatial navigation tasks.